Cost‐effectiveness of transoral robotic surgery versus (chemo)radiotherapy for early T classification oropharyngeal carcinoma: A cost‐utility analysis

The present study is an economic evaluation comparing transoral robotic surgery (TORS) to (chemo)radiotherapy for the management of early T‐classification oropharyngeal cancer.

[1]  Philip Smith,et al.  Cost analysis of open radical cystectomy versus robot‐assisted radical cystectomy , 2018, BJU international.

[2]  E. Genden,et al.  Preferences and utilities for health states after treatment for oropharyngeal cancer: Transoral robotic surgery versus definitive (chemo)radiotherapy , 2014, Head & neck.

[3]  E. Genden,et al.  A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: A systematic review , 2014, The Laryngoscope.

[4]  J. Ellsmere,et al.  Robotic versus laparoscopic Roux-en-Y gastric bypass (RYGB) in obese adults ages 18 to 65 years: a systematic review and economic analysis , 2014, Surgical Endoscopy.

[5]  Harry Quon,et al.  The effect of transoral robotic surgery on short‐term outcomes and cost of care after oropharyngeal cancer surgery , 2014, The Laryngoscope.

[6]  T. Padhya,et al.  Intensity‐modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma , 2013, Head & neck.

[7]  T. Teknos,et al.  Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes. , 2013, JAMA otolaryngology-- head & neck surgery.

[8]  Luke Vale,et al.  Comparative cost-effectiveness of robot-assisted and standard laparoscopic prostatectomy as alternatives to open radical prostatectomy for treatment of men with localised prostate cancer: a health technology assessment from the perspective of the UK National Health Service. , 2013, European urology.

[9]  W. Carroll,et al.  Learning curve for transoral robotic surgery: a 4-year analysis. , 2013, JAMA otolaryngology-- head & neck surgery.

[10]  Jeff Z. Y. Chen,et al.  Early-stage squamous cell carcinoma of the oropharynx: Radiotherapy vs. Trans-Oral Robotic Surgery (ORATOR) – study protocol for a randomized phase II trial , 2013, BMC Cancer.

[11]  H. Quon,et al.  Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16INK4a on treatment outcomes , 2013, The Laryngoscope.

[12]  J. Manola,et al.  Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6–7, 2011, Arlington, Virginia , 2012, Head & neck.

[13]  G. Weinstein,et al.  Transoral robotic surgery: A multicenter study to assess feasibility, safety, and surgical margins , 2012, The Laryngoscope.

[14]  C. Bradford,et al.  Diagnostic modalities for distant metastasis in head and neck squamous cell carcinoma: Are we changing life expectancy? , 2012, The Laryngoscope.

[15]  R. Laborde,et al.  Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma. , 2012, Mayo Clinic proceedings.

[16]  Philippe Després,et al.  Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma. , 2012, International journal of radiation oncology, biology, physics.

[17]  T. Teknos,et al.  Quality-of-Life Outcomes in Transoral Robotic Surgery , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[18]  E. Zinreich,et al.  Factors associated with pharyngoesophageal stricture in patients treated with concurrent chemotherapy and radiation therapy for oropharyngeal squamous cell carcinoma , 2011, Head & neck.

[19]  E. Rosenthal,et al.  Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. , 2011, Archives of otolaryngology--head & neck surgery.

[20]  D. Coyle,et al.  Out-of-pocket costs for accessing adjuvant radiotherapy among Canadian women with breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  E. Horwitz,et al.  Low Rates of Gastrostomy Tube Dependence in Patients with T1-T2 Oropharynx Cancer Treated without Pharyngeal Constrictor Sparing , 2011 .

[22]  E. Genden,et al.  Transoral robotic resection and reconstruction for head and neck cancer , 2011, The Laryngoscope.

[23]  G. Weinstein,et al.  Transoral robotic surgery and human papillomavirus status: Oncologic results , 2011, Head & neck.

[24]  M. Ozsahin,et al.  Mandibular Osteoradionecrosis in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx , 2011, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[25]  E. Rosenthal,et al.  Transoral robotic-assisted surgery for head and neck squamous cell carcinoma: one- and 2-year survival analysis. , 2010, Archives of otolaryngology--head & neck surgery.

[26]  G. Weinstein,et al.  Transoral robotic surgery for advanced oropharyngeal carcinoma. , 2010, Archives of otolaryngology--head & neck surgery.

[27]  Jonathan G. Li,et al.  Intensity‐modulated radiotherapy for oropharyngeal squamous cell carcinoma 1 , 2010, The Laryngoscope.

[28]  G. Barbash,et al.  New technology and health care costs--the case of robot-assisted surgery. , 2010, The New England journal of medicine.

[29]  S. Spencer,et al.  Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. , 2009, International journal of radiation oncology, biology, physics.

[30]  P. Harari,et al.  Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparison. , 2007, International journal of radiation oncology, biology, physics.

[31]  M. Weinstein,et al.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine. , 1996, JAMA.

[32]  A S Detsky,et al.  How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[33]  B. Champagne,et al.  Comparative effectiveness of laparoscopic versus robot-assisted colorectal resection , 2013, Surgical Endoscopy.

[34]  A. Garden,et al.  Clinical Investigation : Head and Neck Cancer Patterns of Disease Recurrence Following Treatment of Oropharyngeal Cancer With Intensity Modulated Radiation Therapy , 2013 .

[35]  Suzanne L Wolden,et al.  Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. , 2012, International journal of radiation oncology, biology, physics.

[36]  T B Lam,et al.  Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer. , 2012, Health technology assessment.